Business Description
NKY Medical Holdings Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000SV3
Share Class Description:
SZSE:300109: Class ACompare
Compare
Traded in other countries / regions
300109.China IPO Date
2010-08-25Description
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.75 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.1 | |||||
| Interest Coverage | 257.46 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 10.21 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.7 | |||||
| 3-Year EBITDA Growth Rate | 56 | |||||
| 3-Year EPS without NRI Growth Rate | 168.3 | |||||
| 3-Year FCF Growth Rate | -13.5 | |||||
| 3-Year Book Growth Rate | 4.9 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.67 | |||||
| 9-Day RSI | 52.81 | |||||
| 14-Day RSI | 55.52 | |||||
| 6-1 Month Momentum % | 8.59 | |||||
| 12-1 Month Momentum % | -24.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.94 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 0.72 | |||||
| Days Inventory | 141.34 | |||||
| Days Sales Outstanding | 86.97 | |||||
| Days Payable | 115.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.4 | |||||
| Dividend Payout Ratio | 0.32 | |||||
| 3-Year Dividend Growth Rate | 192.4 | |||||
| Forward Dividend Yield % | 2.4 | |||||
| 5-Year Yield-on-Cost % | 17.73 | |||||
| Shareholder Yield % | 2.42 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.31 | |||||
| Operating Margin % | 36.04 | |||||
| Net Margin % | 30.61 | |||||
| FCF Margin % | 10.28 | |||||
| ROE % | 14.37 | |||||
| ROA % | 12.59 | |||||
| ROIC % | 15.48 | |||||
| ROC (Joel Greenblatt) % | 39.34 | |||||
| ROCE % | 16.44 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.69 | |||||
| PE Ratio without NRI | 15.33 | |||||
| Shiller PE Ratio | 34.42 | |||||
| Price-to-Owner-Earnings | 22.29 | |||||
| PEG Ratio | 0.76 | |||||
| PS Ratio | 4.18 | |||||
| PB Ratio | 1.81 | |||||
| Price-to-Tangible-Book | 2.09 | |||||
| Price-to-Free-Cash-Flow | 82.13 | |||||
| Price-to-Operating-Cash-Flow | 13.15 | |||||
| EV-to-EBIT | 11.84 | |||||
| EV-to-EBITDA | 11.84 | |||||
| EV-to-Revenue | 4.21 | |||||
| EV-to-FCF | 39.7 | |||||
| Price-to-Projected-FCF | 2.3 | |||||
| Price-to-DCF (Earnings Based) | 1.09 | |||||
| Price-to-DCF (FCF Based) | 7.12 | |||||
| Price-to-Median-PS-Value | 0.69 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.53 | |||||
| Price-to-Graham-Number | 1.11 | |||||
| Price-to-Net-Current-Asset-Value | 9.14 | |||||
| Earnings Yield (Greenblatt) % | 8.45 | |||||
| FCF Yield % | 1.31 | |||||
| Forward Rate of Return (Yacktman) % | 20.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NKY Medical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,615.102 | ||
| EPS (TTM) (Â¥) | 1.53 | ||
| Beta | 0.95 | ||
| Volatility % | 35.29 | ||
| 14-Day RSI | 55.52 | ||
| 14-Day ATR (Â¥) | 0.81136 | ||
| 20-Day SMA (Â¥) | 20.625 | ||
| 12-1 Month Momentum % | -24.03 | ||
| 52-Week Range (Â¥) | 12.03 - 27.26 | ||
| Shares Outstanding (Mil) | 322.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NKY Medical Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NKY Medical Holdings Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
NKY Medical Holdings Ltd Frequently Asked Questions
What is NKY Medical Holdings Ltd(SZSE:300109)'s stock price today?
The current price of SZSE:300109 is ¥20.85. The 52 week high of SZSE:300109 is ¥27.26 and 52 week low is ¥12.03.
When is next earnings date of NKY Medical Holdings Ltd(SZSE:300109)?
The next earnings date of NKY Medical Holdings Ltd(SZSE:300109) is .
Does NKY Medical Holdings Ltd(SZSE:300109) pay dividends? If so, how much?
The Dividend Yield %  of NKY Medical Holdings Ltd(SZSE:300109) is 2.4% (As of Today), Highest Dividend Payout Ratio of NKY Medical Holdings Ltd(SZSE:300109) was 0.67. The lowest was 0.19. And the median was 0.24. The  Forward Dividend Yield % of NKY Medical Holdings Ltd(SZSE:300109) is 2.4%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers